Cleared Traditional

K800857 - HELENA GLYCOSYLATED HEMOGLOBIN QUIK METH

K800857 is an FDA 510(k) clearance for HELENA GLYCOSYLATED HEMOGLOBIN QUIK METH, manufactured by Helena Laboratories. The device is a Class 2 Hematology device with product code LCP cleared through the Traditional 510(k) pathway after a 164-day FDA review.

K800857 · Helena Laboratories · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1980
Decision
164d
Days
Class 2
Risk

K800857 is an FDA 510(k) clearance for the HELENA GLYCOSYLATED HEMOGLOBIN QUIK METH. Classified as Assay, Glycosylated Hemoglobin (product code LCP), Class II - Special Controls.

Submitted by Helena Laboratories (Walker, US). The FDA issued a Cleared decision on September 26, 1980 after a review of 164 days - an extended review cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7470 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Helena Laboratories devices

FDA 510(k) Submission Details - K800857

510(k) Number K800857 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 15, 1980
Decision Date September 26, 1980
Days to Decision 164 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
51d slower than avg
Panel avg: 113d · This submission: 164d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LCP Device Classification - Class 2, Special Controls

Product Code LCP Assay, Glycosylated Hemoglobin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7470
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - LCP Assay, Glycosylated Hemoglobin

All 202
Devices cleared under the same product code (LCP) and FDA review panel - the closest regulatory comparables to K800857.
SANDARE GLYCOHEMOGLOBIN PROCEDURE
K802832 · Sandare Chemical Co., Inc. · Jan 1981
GLYCOHEMOGLOBIN IN WHOLE BLOOD
K802721 · Sigma Chemical Co. · Dec 1980
GLYCOSYLATED HEMOGLOBIN-SMC COLUMN
K802233 · Helena Laboratories · Oct 1980
GLYCOSYLATED HEMOGLOBIN KIT
K801561 · Amersham Corp. · Aug 1980
SANDARE LYOPHILIZED GLYCOHEMOGLOBIN CLS.
K801422 · Sandare Chemical Co., Inc. · Jul 1980
LEECO GLYCO-HEMOGLOBIN DIAG. TEST KIT
K801289 · Leeco Diagnostics, Inc. · Jun 1980